About Weishengkang Medical Technology
Weishengkang Medical Technology is a company based in Suzhou (China) founded in 2020.. Weishengkang Medical Technology has raised $15.7 million across 1 funding round from investors including SDIC Unity Capital and Baisichuang. Weishengkang Medical Technology operates in a competitive market with competitors including Plastiflex, Vyaire, Third Pole Therapeutics, Resvent and OmniSpirant, among others.
- Headquarter Suzhou, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.7 M (USD)
in 1 rounds
-
Latest Funding Round
$15.7 M (USD), Series A
Mar 30, 2022
-
Investors
SDIC Unity Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Weishengkang Medical Technology
Weishengkang Medical Technology has successfully raised a total of $15.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.7 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $15.7M
-
First Round
First Round
(30 Mar 2022)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series A - Weishengkang Medical Technology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Weishengkang Medical Technology
Weishengkang Medical Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include SDIC Unity Capital and Baisichuang. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A professional guiding and industrial fund management institution is operated.
|
Founded Year | Domain | Location | |
|
Baisichuang is engaged in producing TPU-based automotive protective films.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Weishengkang Medical Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Weishengkang Medical Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Weishengkang Medical Technology Comparisons
Competitors of Weishengkang Medical Technology
Weishengkang Medical Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Plastiflex, Vyaire, Third Pole Therapeutics, Resvent and OmniSpirant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hose systems and related components are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Respiratory devices for diagnostics, ventilation, and patient monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Developer of devices for cardiopulmonary therapies
|
|
| domain | founded_year | HQ Location |
A suite of respiratory healthcare devices is developed.
|
|
| domain | founded_year | HQ Location |
Developing inhaled regenerative gene therapy for cystic fibrosis and COPD
|
|
| domain | founded_year | HQ Location |
Respiratory devices for ICU settings are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Weishengkang Medical Technology
Frequently Asked Questions about Weishengkang Medical Technology
When was Weishengkang Medical Technology founded?
Weishengkang Medical Technology was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Weishengkang Medical Technology located?
Weishengkang Medical Technology is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Weishengkang Medical Technology a funded company?
Weishengkang Medical Technology is a funded company, having raised a total of $15.7M across 1 funding round to date. The company's 1st funding round was a Series A of $15.7M, raised on Mar 30, 2022.
What does Weishengkang Medical Technology do?
Weishengkang Medical Technology was founded in 2020 in Suzhou, China, operating in the medical technology sector. Respiratory support equipment and platform management devices are developed, including extracorporeal membrane oxygenation (ECMOECCO2R), intelligent airway management systems, high-flow oxygen therapy systems, and consumables. Focus is placed on respiratory care and patient monitoring through these systems and related products.
Who are the top competitors of Weishengkang Medical Technology?
Weishengkang Medical Technology's top competitors include Plastiflex, Vyaire and Third Pole Therapeutics.
Who are Weishengkang Medical Technology's investors?
Weishengkang Medical Technology has 2 investors. Key investors include SDIC Unity Capital, and Baisichuang.